Brief: Entrada Therapeutics Inc Shares Open 32.5% Above IPO Price In Nasdaq Debut
29/10/2021 16:24
Oct 29 (Reuters) -
* ENTRADA THERAPEUTICS INC SHARES OPEN AT $26.50 IN NASDAQ
DEBUT
VERSUS IPO PRICE OF $20.00/SHARE
Further company coverage: TRDA.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Entrada Therapeutics
See all newsBrief: Entrada Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
Entrada Therapeutics, Inc. reports results for the quarter ended June 30 - Earnings Summary
Brief: Entrada Therapeutics Q2 Collaboration Revenue USD 898 Thousand
Entrada Therapeutics Q2 net loss narrows on lower costs
Entrada Therapeutics Inc expected to post a loss of $1.05 a share - Earnings Preview